Bing

SEARCH HISTORY

Inovio Pharmaceuticals (NASDAQ:INO)‘s stock had its “buy” rating reiterated by stock analysts at Maxim Group in a report issued on Friday, AnalystRatings.Net reports. They currently have a $20.00 price target on the biopharmaceutical company’s …
Mideast Times · 7/27/2015
Inovio Pharmaceuticals
In-depth coverage >
INO's auto-centering technology is 10 to 20 times more precise than the conventional drop-in technique, and is faster than machine-assisted methods while providing comparable alignment precision. Easy to implement, this method works with most optical ...
Financial Content · 7/28/2015
INO
This analysis was compiled based on yesterday's trading activity as we search for stocks that have could possible underperform ... Inovio Biomedical (AMEX:INO) follows with a loss of 2.43% and PDL BioPharma (NASDAQ:PDLI) rounds out the bottom five …
Financial News Network Online · ByPeter Chu · 1 day ago
More from Bing News
Inovio Pharmaceuticals (NASDAQ:INO)‘s stock had its “buy” rating reaffirmed by analysts at Maxim Group in a research report issued to clients and investors on Friday, Analyst Ratings Net reports. They currently have a $20.00 price target on the ...
Ticker Report · 7/24/2015
Inovio Pharmaceuticals
Investors in Inovio Pharmaceuticals Inc. (INO) saw new options begin trading this week, for the September 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the INO options …
The Street · 7/21/2015
Interested in a cure for cancer? HIV? Hepatitis B? Influenza? Inovio Pharmaceuticals Inc (NASDAQ:INO) has taken that hope on step further. It’s working on vaccines for all these. And it’s getting pretty impressive results. So much so that INO will ...
Investor Place · 4/15/2015
Inovio Pharmaceuticals Inc:Inovio Pharmaceuticals and European organization for research and treatment of cancer to collaborate on large phase II cervical cancer trial.The cervical cancer trial, primarily funded by the eortc, is expected to begin by the ...
Reuters · 7/23/2015
When the deal was announced back in 2013, INO stock bounced up 15%, and it was certainly thought of as a major event. Therefore it is somewhat disconcerting to learn that Dr. Joseph Kim, the CEO of Inovio, stated that Roche's decision to return the …
Seeking Alpha · 1/18/2015
IG closed Thursday's trading at $6.78, down 1.60%. In after hours, the stock was up 6.19% to $7.20. Inovio Pharmaceuticals Inc. (INO) has teamed up with the European Organization for Research and Treatment of …
Realtime Business News · 7/24/2015
One stock that might be an intriguing choice for investors right now is Inovio Pharmaceuticals, Inc. ( INO). This is because this security in the medical space is seeing solid earnings estimate revision activity, and is in great company from a Zacks ...
NASDAQ · 12/5/2014